The study was carried out at 24 clinical sites across the UK and included 303 participants.

About 3 million FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors manufactured by Abbott were recalled in November, because they might give wrong readings.

Should A1c remain the gold standard for routine monitoring of glucose control in people with diabetes, or is it time to shift ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The FDA granted clearance for a standalone reader to be ...

Abbott (NYSE: ABT), a global healthcare leader, today announced results from the FreeDM2 randomized controlled trial (RCT) showing that people using FreeStyle Libre continuous glucose monitoring (CGM) ...

They say a rising tide lifts all boats, and that certainly seems to be the case with the new wave of drugs and devices for diabetes management. In a recent analysis (PDF), Abbott examined trends in ...

Abbott Diabetes Care's Freestyle Libre Flash Glucose Monitoring System has been approved by the FDA. As well as finally bringing the system, which is already available in 39 other countries, home to ...

Correction: A previous version of this article failed to specify that the deal concerns Freestyle Libre Pro, rather than the consumer version, Freestyle Libre. Livongo Health, the digital chronic ...

As it embarks on a widespread effort to remind users of the proper care and keeping of the hand-held readers used with its FreeStyle Libre continuous glucose monitors, Abbott is further expanding the ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The Tandem t:slim X2 insulin pump can now integrate with ...

DURHAM, N.C.--(BUSINESS WIRE)--Validic, a leader in digital health and personalized care technology, today announced a significant advancement in diabetes management: the integration of continuous ...